Error: Could not add to watchlist. X
+ Watchlist

Credit Suisse Lux Global Biotech Innovators Equity Fund

CLABI1B:LX
440.07
USD
5.26
1.18%
As of 12:59 AM EST 2/22/2017
Fund Type
SICAV
52Wk Range
355.76 - 449.76
1 Yr Return
19.33%
YTD Return
11.29%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Previous Close
445.33
52Wk Range
355.76 - 449.76
1 Yr Return
17.17%
YTD Return
11.29%
Fund Type
SICAV
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
International
NAV (on 02/22/2017)
440.07
Total Assets (m USD) (on 02/22/2017)
163.264
Inception Date
10/05/2001
Last Dividend (on -)
-
Dividend Indicated Gross Yield
-
Fund Managers
THOMAS AMREIN
Front Load Fee
3.00%
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
-
Current Mgmt Fee
0.90%
Expense Ratio
1.17%

Top Fund Holdings

Name Position Value % of Fund
117.28 k 13.57 m 9.08
168.00 k 12.03 m 8.05
38.00 k 10.78 m 7.21
26.00 k 9.54 m 6.38
67.00 k 6.72 m 4.49
52.75 k 6.45 m 4.32
43.00 k 6.29 m 4.21
65.44 k 5.42 m 3.63
70.00 k 5.16 m 3.45
39.00 k 4.99 m 3.34
Profile
Credit Suisse Lux Global Biotech Innovators Equity Fund is a SICAV incorporated in Luxembourg. The Fund is actively managed aiming to outperform the return of the NASDAQ Biotechnology TR benchmark. The Fund mainly invests in equity and equity-type securities of issuers engaged in the biotechnology industry.
Address
Credit Suisse AG
Kalanderplatz 1
8070 Zurich
Switzerland
Tel: +41 44 333 40 50
Phone
-